EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma

Stefano Marletta, Denise Fiorini, Anna Caliò, Lisa Marcolini, Lavinia Stefanizzi, Cinzia Giacometti, Serena Pedron, Caterina Vicentini, Guido Martignoni

Virchows Archiv · 2026

DOI: 10.1007/s00428-026-04536-9 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Virchows Archiv, 2026. Verfasst von Stefano Marletta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Humanitas University, Milan, Italy. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Biomarkers, Tumor, Carcinoma, Papillary. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bando di ricerca finalizzata 2021, Università degli Studi di Verona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Papillary renal neoplasm with reverse polarity (PRNRP) is a recently recognized renal tumor characterized by papillary architecture lined by a single layer of low-grade eosinophilic cells with apically located nuclei. In the latest WHO classification, they are not recognized as a distinct entity but rather as a morphological pattern of papillary renal cell carcinoma. To date, limited studies have compared PRNRP with eosinophilic/oncocytic papillary renal cell carcinoma (E/OPRCC), which they are not infrequently confused with, although a few previous comparisons with classic papillary renal cell carcinoma have already identified several distinguishing features. A comparative analysis of 15 of PRNRPs and 16 of E/OPRCC cases was conducted, evaluating their histopathological, immunophenotypic, interphase cytogenetic, and molecular profiles. PRNRPs demonstrated distinctive morphological features, including consistent apical nuclear positioning, absence of foamy macrophages in the papillary cores ( p = 0.0001), and a lower nucleolar grade compared to E/OPRCCs (p = < 0.0001). Immunohistochemically, PRNRPs exhibited strong and uniform GATA3 expression and were negative for vimentin, CD10, and CD13, in contrast to E/OPRCCs. Cytogenetically, PRNRPs lacked trisomies of chromosomes 7 and 17, which were present in ~ 40% of E/OPRCCs (p = 0.0262). Notably, all PRNRP cases harbored KRAS mutations, absent in E/OPRCCs ( p < 0.0001). Our findings support the classification of PRNRP as a distinct renal tumor entity, separated from both classic papillary renal cell carcinoma and its eosinophilic/oncocytic morphological variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellBiomarkers, TumorCarcinoma, PapillaryHumansFemaleMaleMiddle AgedAgedImmunohistochemistryWorld Health OrganizationAdultMutationEosinophilsEosinophilia

Stichwörter der Autor:innen

Differential diagnosisEosinophilic/oncocytic papillary renal cell carcinomaOncocytic renal tumorsPapillary renal neoplasm with reverse polarity

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biomedical Science, Humanitas University, Milan, Italy.
  • Division of Pathology, Humanitas Istituto Clinico Catanese, Catania, Italy.
  • Department of Pathology and Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.
  • Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Largo L. Scuro 10, 37134, Verona, Italy.
  • Department of Pathology and Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy. guido.martignoni@univr.it.
  • Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Largo L. Scuro 10, 37134, Verona, Italy. guido.martignoni@univr.it.

Förderung

  • Bando di ricerca finalizzata 2021
  • Università degli Studi di Verona

Zitieren

APA

Marletta, S., Fiorini, D., Caliò, A., Marcolini, L., Stefanizzi, L., Giacometti, C., Pedron, S., Vicentini, C., & Martignoni, G. (2026). Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma. Virchows Archiv. https://doi.org/10.1007/s00428-026-04536-9

Vancouver

Marletta S, Fiorini D, Caliò A, Marcolini L, Stefanizzi L, Giacometti C, et al. Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma. Virchows Archiv. 2026. doi:10.1007/s00428-026-04536-9

BibTeX
@article{Marletta2026,
  author = {Marletta, Stefano and Fiorini, Denise and Caliò, Anna and Marcolini, Lisa and Stefanizzi, Lavinia and Giacometti, Cinzia and Pedron, Serena and Vicentini, Caterina and Martignoni, Guido},
  title = {Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma},
  journal = {Virchows Archiv},
  year = {2026},
  doi = {10.1007/s00428-026-04536-9}
}
Kostenlos starten →